Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05326386 · ClinicalTrials.gov registry record · NA
Gamification and Medication Adherence (GAME Adherence)
A NA study of Hypertension and Hyperlipidemia, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT05326386: Active NA study of Hypertension and Hyperlipidemia, sponsored by University of Pennsylvania.
NCT05326386 is a NA study of Hypertension and Hyperlipidemia that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05326386, a NA study of Hypertension and Hyperlipidemia, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
A two-arm randomized controlled trial to evaluate whether a gamification intervention plus involvement of a supportive partner (social support) and sending reports to physicians (accountability) increases medication adherence in patients with hypertension and hyperlipidemia. The study will randomize 84 patients with hypertension, hyperlipidemia, and a history of poor medication adherence seen in a single Penn Medicine clinic to an 18-week gamification intervention or to attention control text messages alone.
Primary Outcome
Patient reported adherence will be defined as days taking all prescribed antihypertensive medications and statins divided by total days in the study over the entire study duration; this will be compared between study arms
Conditions Studied
Interventions
- BEHAVIORAL HTN and Medication Adherence
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2026-05 |
| Phase | NA |
What the registry record for NCT05326386 still lists
NCT05326386 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Hypertension and Hyperlipidemia appearing as the primary indexed condition, and to 1 intervention - of which HTN and Medication Adherence is the first listed.
NCT05326386 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05326386 about?
NCT05326386 is a clinical study titled "Gamification and Medication Adherence (GAME Adherence)". A two-arm randomized controlled trial to evaluate whether a gamification intervention plus involvement of a supportive partner (social support) and sending reports to physicians (accountability) increases medication adherence in patients with hypertension and hyperlipidemia. The study will randomize...
What is the current status of trial NCT05326386?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2022-09-12. Estimated completion is 2026-05.
What conditions does trial NCT05326386 study?
This clinical trial studies the following conditions: Hypertension and Hyperlipidemia.
What interventions are being tested in trial NCT05326386?
The interventions under investigation include: HTN and Medication Adherence (BEHAVIORAL).
Who is sponsoring clinical trial NCT05326386?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05326386 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05326386's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI